logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11141424 B1

PDFFull Text
Date of Patent:
Oct. 12, 2021

Filed:

May. 02, 2018

Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (ph 6.1 to 7.9) with increased storage stability for treating cystitis

Applicant:

Farco-pharma Gmbh, Cologne, DE;

Inventor:

Andreas Meier, Cologne, DE;

Assignee:

FARCO-PHARMA GMBH, Cologne, DE;

Attorneys:

Edward E. Sowers

Brannon Sowers & Cracraft PC

Primary Examiner:

Leigh C Maier

Int. Cl.
CPC ...
A61K 31/728 (2006.01); A61P 13/10 (2006.01); A61K 31/737 (2006.01); A61K 47/02 (2006.01); A61M 3/02 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/728 (2013.01); A61K 9/0034 (2013.01); A61K 9/08 (2013.01); A61K 31/737 (2013.01); A61K 47/02 (2013.01); A61M 3/0266 (2013.01); A61P 13/10 (2018.01);
Abstract

The invention relates to a composition, in particular a pharmaceutical composition, which is suitable in particular for the prophylactic and/or therapeutic treatment preferably of inflammatory diseases of the urogenital tract, in particular inflammatory diseases of the bladder, preferably cystitis, to the uses thereof, to a storage or application device relating to same, to a packaging unit, and finally to a kit which is designed in particular as an instillation system.

Find Patent Forward Citations

Meier, Andreas. (2021). Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (ph 6.1 to 7.9) with increased storage stability for treating cystitis (U.S. Patent No. 11141424). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11141424

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…